---
title: "Trump reciprocal tariffs on EU could hit pharma manufacturing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/234284775.md"
description: "President Trump announced a 20% reciprocal tariff on the EU, impacting major drugmakers like Merck and AbbVie. This move responds to the EU's 39% tariff on US goods. Analysts from TD Cowen noted that while some companies are well-positioned, others may face challenges. In response, firms like Eli Lilly and Johnson & Johnson are increasing US manufacturing investments, with Eli Lilly committing $27 billion for new sites. Trump emphasized that pharmaceutical companies must adapt or face significant taxes."
datetime: "2025-04-02T22:01:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/234284775.md)
  - [en](https://longbridge.com/en/news/234284775.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/234284775.md)
generator: "portal-rs"
---

# Trump reciprocal tariffs on EU could hit pharma manufacturing

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on Wednesday from the Rose Garden.

That includes a 20% reciprocal tariff for the European Union, which includes Ireland. According to Trump, this is in response to a 39% tariff the EU levies on the US. The tariffs go into effect Thursday.

In a note to clients earlier Wednesday, TD Cowen analysts said the companies with the most exposure to tariffs on Ireland were Merck and AbbVie (ABBV).

Still, AbbVie, Bristol Myers Squibb (BMY), and Eli Lilly "appear relatively well-positioned with more major U.S. plants than outside the United States, and most API sites in the U.S.," the analysts said.

API, or active pharmaceutical ingredients, are the base compounds used to develop drugs. They are often created in bulk, and countries like India are key sources outside the US for supplying these ingredients.

"After Ireland (22 sites), the countries with the most FDA registered drug manufacturing sites are France (20), Germany (14), Italy (13) and Singapore (12)," according to TD Cowen, adding that 82% of the non-US plants are in the EU.

US President Donald Trump holds a chart as he delivers remarks on reciprocal tariffs during an event in the Rose Garden entitled "Make America Wealthy Again" at the White House in Washington, DC, on April 2, 2025. Trump geared up to unveil sweeping new "Liberation Day" tariffs in a move that threatens to ignite a devastating global trade war. Key US trading partners including the European Union and Britain said they were preparing their responses to Trump's escalation, as nervous markets fell in Europe and America. (Photo by Brendan SMIALOWSKI / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images) · BRENDAN SMIALOWSKI via Getty Images

In anticipation of the tariff impact, some companies have committed to growing their US manufacturing presence, including Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck (MRK). Others are likely going to begin tech transfers to US sites that will take roughly 12 to 18 months.

Eli Lilly notably announced $27 billion to build out four new sites in the US. Trump said Johnson & Johnson committed to $55 billion to build more US plants, and Merck committed to spending about $8 billion by 2028.

"The pharmaceutical companies are going to come roaring back. If they don't, they're going to have a very big tax to pay," Trump said Wednesday.

*Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee on social media platforms X, LinkedIn, and Bluesky @AnjKhem.*

**Click here for in-depth analysis of the latest health industry news and events impacting stock prices**

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker](https://longbridge.com/en/news/306367494.md)
- [Starknet: Scheduled unlock releases up to 127 million STRK - 15 Dec 2026](https://longbridge.com/en/news/306371387.md)
- [Russia says cargo vessel attacked by drones in Gulf of Finland](https://longbridge.com/en/news/306365729.md)
- [Persona Earns CEN/TS 18099 High Certification for Injection Attack Detection](https://longbridge.com/en/news/306371119.md)
- [VAPORES: Hapag-Lloyd earnings drove results as cash fell and shipping risks persisted](https://longbridge.com/en/news/306365546.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**